This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
CD2_BENIGN_CONNSOFT_LOWERLIMB_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi/textus mollis coxae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Connective and other soft tissue of lower limb, including hip
- Other benign neoplasms of connective and other soft tissue
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 865 | 524 | 341 |
| Unadjusted period prevalence (%) | 0.17 | 0.18 | 0.15 |
| Median age at first event (years) | 48.19 | 46.95 | 50.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 779
- Matched controls
- 7788
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
+∞
323.0
549
*
21504
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Extremitatis inferioris (regione glutaea inclusa)
+∞
123.3
115
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
38.9
104.5
133
41
2153C
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,HERMOPERÄINEN]
+∞
49.5
47
*
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
147.7
40.1
42
*
115
Kela drug reimbursment
Breast cancer
+∞
38.9
37
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
38.9
37
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
37.8
36
*
H02AB02
ATC
dexamethasone; systemic
20.7
37.6
56
29
130
Kela drug reimbursment
Malignant tumour
+∞
36.8
35
*
PJA12
NOMESCO Finland
Sentinel node biopsy
362.7
35.2
35
*
2153A
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,SIDEKUDOSPERÄI]
+∞
33.6
32
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
122.0
32.9
35
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
30.4
29
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
13.5
30.3
53
42
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
17.9
28.3
44
26
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
12.7
27.3
49
41
2153X
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,TARK MÄÄRITTEL]
+∞
27.2
26
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
100.3
26.8
29
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
26.2
25
*
A04AA02
ATC
granisetron; systemic, transdermal
269.1
25.8
26
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
60.1
25.2
29
5
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
247.2
23.8
24
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
48.3
23.5
28
6
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
8.5
23.0
51
64
HAC20
NOMESCO Finland
Total mastectomy
123.6
22.7
24
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
22.0
21
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
44.7
21.5
26
6
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
20.9
20
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
20.9
20
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
79.0
20.8
23
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
27.9
20.1
27
10
116
Kela drug reimbursment
Prostate cancer
+∞
19.9
19
*
WF002
NOMESCO Finland
Radical radiotherapy
41.2
19.6
24
6
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
11.4
19.4
36
33
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.1
19.4
62
129
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
18.8
18
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
18.5
125
488
XX3DW
NOMESCO Finland
Time consuming IT work
4.5
18.1
65
153
WX320
NOMESCO Finland
Spinalanesthesy
2.2
17.9
207
1080
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
17.8
84
253
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
17.8
17
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
17.8
17
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
17.8
17
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.1
17.4
69
179
JN4BD
NOMESCO Finland
Extensive body CT
4.6
17.1
60
138
L02BG04
ATC
letrozole; oral
12.5
16.4
29
24
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
7.2
15.8
38
55
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
15.7
15
*
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
11.1
15.1
28
26
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
14.8
218
1244
WZC30
NOMESCO Finland
Teaching
2.9
14.8
94
352
HA1AA
NOMESCO Finland
X-ray mammography
5.4
14.7
44
85
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.6
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.6
14
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
9.9
13.8
27
28
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
13.6
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
13.6
13
*
JN4AD
NOMESCO Finland
Body CT examination
5.0
13.5
43
90
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.7
13.2
33
51
NK6AN
NOMESCO Finland
Total body bone isotope imaging
40.8
13.2
16
*
ZXA00
NOMESCO Finland
Right side
2.0
13.2
216
1279
A04AA01
ATC
ondansetron; systemic, rectal
5.1
13.1
41
84
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.9
13.0
42
89
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.1
12.9
50
128
NHM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot
17.7
12.6
19
11
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
12.5
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.5
12
*
9474
FHL
Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)
21.7
12.0
17
8
N03AX16
ATC
pregabalin; oral
2.0
11.8
185
1071
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
9.1
11.8
24
27
S18
ICPC
Laceration/cut
1.8
11.7
300
2051
L01BC06
ATC
capecitabine; oral
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
Y77
ICPC
Malignant neoplasm prostate
121.7
11.5
12
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
11.4
277
1858
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
8.0
11.4
25
32
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
11.3
229
1449
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
35.6
11.3
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
11.0
182
1074
L03AA02
ATC
filgrastim; parenteral
60.8
10.6
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
111.4
10.4
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.4
10
*
A04AD12
ATC
aprepitant; systemic
+∞
10.4
10
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
33.0
10.4
13
*
Z51.5
ICD-10 Finland
Palliative care
5.8
10.2
28
50
D21.9
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue, unspecified
17.0
9.9
15
9
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
10.8
9.8
18
17
WX402
NOMESCO Finland
General anaesthesia
2.2
9.8
107
532
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
101.2
9.4
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
101.2
9.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
101.2
9.4
10
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
9.4
9
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
9.4
9
*
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
22.0
9.4
13
6
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
6.5
9.3
23
36
M67.4
ICD-10 Finland
Ganglion
2.7
9.2
65
258
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
37.1
9.0
11
*
L02BA01
ATC
tamoxifen; oral
37.1
9.0
11
*
SPAT1153
SPAT
Removal of sutures
1.7
8.9
227
1523
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
24.3
8.9
12
5
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
8.8
341
2558
ZXA05
NOMESCO Finland
Left side
1.7
8.5
182
1156
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
91.0
8.4
9
*
B01AB05
ATC
enoxaparin; parenteral
1.7
8.4
197
1287
2153B
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,LIHASKUDOSPERÄ]
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
8.3
8
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
8.3
8
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
8.3
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
8.3
285
2065
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
8.3
137
800
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
8.0
78
369
WX002
NOMESCO Finland
Sedation and analgesia
1.8
8.0
145
875
UKC02
NOMESCO Finland
Cystoscopy
2.0
7.9
104
558
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
10.9
7.8
14
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.4
7.7
22
42
N02BE01
ATC
paracetamol; systemic, rectal
1.7
7.6
630
5589
NH3CG
NOMESCO Finland
Extensive MRI of foot
12.0
7.6
13
11
NF3AA
NOMESCO Finland
Femur X-ray examination
5.2
7.6
22
43
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
25.3
7.6
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.5
133
792
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
4.2
7.4
26
63
ZZR00
NOMESCO Finland
Flap of skin
11.0
7.3
13
12
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
2153D
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,MUU]
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
J01DB01
ATC
cefalexin; oral
1.6
7.2
599
5267
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
30.3
7.2
9
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.3
7.2
25
60
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.4
7.1
58
250
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
7.0
34
108
WX110
NOMESCO Finland
Local anesthesy
1.5
7.0
479
4012
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
5.2
7.0
20
39
N02AX02
ATC
tramadol; systemic, rectal
1.5
6.9
291
2193
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.2
6.8
24
58
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.3
6.7
23
55
B01AB10
ATC
tinzaparin; parenteral
2.9
6.6
39
141
N02AA05
ATC
oxycodone; systemic
2.0
6.5
78
403
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
6.5
661
6006
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
6.5
25
66
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.4
6.4
7
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
70.4
6.4
7
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
14.4
6.4
10
7
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
14.4
6.4
10
7
N03AX12
ATC
gabapentin; oral
1.8
6.4
118
712
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.6
6.3
17
31
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.6
6.3
20
44
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
6.3
6
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
A06AH03
ATC
naloxegol; oral
26.9
6.2
8
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
6.2
93
526
M79.6
ICD-10 Finland
Pain in limb
1.5
6.2
258
1927
7354A
ICD-9 Finland
Acquired deformities of toe, Other hammer toe (acquired)
7.8
6.1
13
17
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
12.6
6.1
10
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
6.0
84
459
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
6.0
68
343
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
83
322
2.75
15.15
3.7
1.4
35.7
3.6
ug/l
0.62
67
244
438
3181
1.76
14.80
5.9
3.6
11.4
11.5
umol/l
0.03
407
2970
130
630
2.25
14.72
3.4
2.9
—
—
—
0
0
627
5101
1.83
13.89
8.6
5.2
79.6
75.2
u/l
1.18
586
4711
313
2115
1.75
13.22
2.9
2.0
2.4
2.4
mmol/l
1.00
252
1763
396
2930
1.65
11.48
4.1
3.7
—
—
—
0
0
465
3651
1.59
10.10
8.8
6.5
4.3
4.2
e9/l
0.17
413
3174
52
196
2.76
10.04
1.5
1.4
—
—
—
0
0
612
5184
1.62
9.20
4.9
4.1
12.0
11.3
mm/h
0.57
562
4781
768
6953
1.93
8.65
16.8
11.8
19.3
22.3
mg/l
2.19
637
5317
376
2885
1.54
8.54
7.0
5.0
1.2
1.2
mmol/l
2.06
329
2575
409
3208
1.52
8.32
7.2
5.5
1.2
1.2
mmol/l
1.92
321
2736
44
169
2.69
8.23
1.5
1.6
4368.7
12058.7
e6/l
1.73
25
125
364
2850
1.48
7.12
2.5
2.3
77.2
77.6
nmol/l
0.09
319
2542
348
2717
1.47
6.83
5.2
3.6
35.6
35.9
g/l
0.51
324
2511
277
2076
1.49
6.64
2.8
2.3
56.2
57.8
u/l
0.36
248
1901
240
1747
1.52
6.62
2.8
2.3
352.8
6307.4
umol/l
6.18
201
1516
84
465
1.89
6.55
5.8
2.6
1.2
1.2
mmol/l
0.12
75
387
781
7242
1.81
6.28
18.3
13.9
139.5
139.7
mmol/l
0.97
758
7017
782
7257
1.81
6.22
18.5
14.0
4.0
4.0
mmol/l
0.05
761
7022
189
1326
1.54
6.13
3.0
2.4
5.1
6.5
e6/l
0.85
171
1141
10
8
12.63
6.09
1.0
1.1
—
—
—
0
0
468
3918
1.42
6.06
5.0
4.1
6.7
6.7
mmol/l
0.05
442
3627
76
418
1.90
6.06
1.5
1.6
—
—
—
0
0
20
60
3.39
5.75
2.0
1.4
28.9
35.2
%
0.24
13
35
233
1735
1.47
5.62
3.3
2.8
0.4
0.4
e6/l
0.09
188
1281
718
6576
1.54
5.35
15.2
10.5
81.0
80.8
ml/min/173m2
0.09
615
5270
120
792
1.60
5.03
6.7
4.8
1.0
1.0
mmol/l
0.18
110
720
35
154
2.33
5.02
1.6
1.5
—
—
—
0
0
618
5530
1.41
4.90
4.2
4.0
15.0
14.8
pmol/l
0.85
542
5037
238
1821
1.42
4.88
5.6
3.8
0.0
0.0
estimate
0.88
101
589
93
582
1.67
4.82
5.5
2.9
228.6
241.2
u/l
0.85
83
544
510
4429
1.37
4.80
5.6
4.4
61.9
3131.9
e6/l
—
8
61
714
6576
1.49
4.72
5.1
4.8
1.9
2.1
mu/l
0.59
636
6021
173
1258
1.47
4.63
1.3
1.3
21.3
33.2
iu/ml
1.47
50
415
140
981
1.51
4.49
2.6
2.3
13.9
13.5
umol/l
0.30
127
895
119
806
1.55
4.46
2.9
2.4
24.2
23.5
%
0.20
95
682
321
2631
1.35
4.23
4.0
3.7
30.8
51.5
ng/l
0.77
215
1784
166
1219
1.45
4.20
1.3
1.3
11.4
12.7
u/ml
0.08
64
469
265
2118
1.36
4.09
3.2
2.6
39.8
32.7
u/l
0.40
254
2021
793
7523
1.65
4.06
12.2
8.7
26.4
25.7
u/l
0.50
763
7216
699
6464
1.42
4.04
15.2
12.9
40.0
40.1
%
0.10
460
4588
125
884
1.48
3.83
2.8
2.3
2.4
2.3
g/l
1.18
113
822
23
96
2.43
3.75
1.9
1.5
66.5
61.5
%
0.20
13
63
25
109
2.33
3.71
1.7
2.3
15.3
16.4
%
—
10
55
17
61
2.82
3.70
1.3
1.3
2215.3
164783.9
e6/l
—
9
41
100
680
1.53
3.69
3.0
2.1
9.1
7.0
umol/l
0.54
84
578
346
2911
1.31
3.69
2.1
2.0
94.6
96.2
pmol/l
0.20
180
1460
27
124
2.22
3.57
3.1
3.5
58.7
57.5
%
0.23
27
124
76
494
1.59
3.43
2.1
1.9
0.2
0.2
g/l
0.41
71
454
18
70
2.60
3.40
2.4
1.9
34.0
33.0
pg
0.50
18
70
26
121
2.18
3.35
2.7
3.2
4.0
4.1
e9/l
0.10
26
121
24
108
2.26
3.34
1.9
1.6
—
—
—
0
0
632
5816
1.32
3.26
17.9
14.2
13.7
13.6
%
1.12
621
5674
38
207
1.87
3.22
2.3
1.8
3.6
1.5
ug/l
0.37
31
183
73
481
1.57
3.13
3.0
1.5
65.5
67.5
g/l
1.47
62
429
33
175
1.92
3.04
1.4
1.2
—
—
—
0
0
817
7881
1.66
2.98
24.5
17.6
134.8
136.1
g/l
1.64
804
7747
5
5
10.05
2.98
1.0
2.4
—
—
—
0
0
394
3439
1.27
2.98
4.7
3.6
0.0
0.0
estimate
0.38
103
588
170
1333
1.34
2.88
2.1
1.7
1076.7
1186.1
nmol/l
0.95
116
1004
505
4554
1.26
2.84
3.1
2.9
49.0
43.8
u/l
0.67
471
4245
387
3388
1.26
2.80
4.7
3.6
0.0
0.0
estimate
0.00
102
599
29
152
1.94
2.78
3.7
1.3
39.9
42.2
mg/l
0.09
18
126
29
152
1.94
2.78
3.7
1.3
53.4
30.4
mg/l
0.52
18
125
388
3402
1.25
2.76
5.7
4.9
0.0
0.0
estimate
0.50
104
600
154
1200
1.34
2.72
3.3
2.1
2.5
2.4
mmol/l
5.90
132
1029
131
998
1.37
2.67
2.1
1.8
—
—
—
0
0
121
910
1.38
2.67
3.2
2.5
0.8
0.8
mmol/l
0.18
107
846
255
2134
1.28
2.67
2.4
2.1
164.4
236.5
u/l
1.01
238
2013
77
535
1.48
2.62
3.6
3.7
108.0
85.3
ng/l
0.47
62
472
178
1427
1.31
2.58
2.5
2.0
—
—
—
0
0
699
6597
1.31
2.53
6.0
5.8
39.7
39.8
mmol/mol
0.11
626
6124
26
139
1.90
2.38
2.6
1.6
—
—
—
0
0
75
529
1.46
2.38
3.3
2.2
63.5
67.1
ml/min/173m2
0.32
29
212
51
334
1.56
2.30
2.9
2.7
0.2
0.2
e6/l
0.20
51
324
304
2639
1.23
2.26
5.0
3.7
—
—
—
0
0
134
1054
1.32
2.23
2.6
2.5
1.7
1.6
e6/l
0.12
86
581
86
632
1.40
2.20
2.4
1.8
359.2
361.7
nmol/l
0.04
77
572
340
2995
1.22
2.18
2.9
2.7
133.9
111.9
ug/l
1.13
305
2751
19
95
2.02
2.12
1.3
1.2
—
—
—
0
0
38
237
1.63
2.11
1.9
1.6
—
—
—
0
0
261
2245
1.23
2.09
4.7
3.9
12.5
8.2
mg/mmol
0.68
152
1406
40
254
1.60
2.07
1.9
1.7
—
—
—
0
0
124
978
1.31
2.03
2.7
2.7
2.2
3.0
e6/l
0.70
74
509
263
2271
1.23
2.02
3.5
3.1
7.1
7.5
mmol/l
0.96
201
1915
8
26
3.10
2.01
2.5
2.4
—
—
—
0
0
228
1941
1.24
2.00
5.2
3.6
1.8
1.9
ug/l
0.15
197
1743
6
16
3.77
1.93
6.3
1.8
—
—
—
0
0
24
135
1.80
1.93
1.3
2.0
137.4
132.1
g/l
0.55
17
105
34
212
1.63
1.91
1.7
1.7
—
—
—
0
0
34
213
1.62
1.88
1.7
1.6
0.1
0.1
iu/ml
—
10
42
478
4396
1.20
1.85
3.1
3.0
—
—
—
0
0
139
1128
1.28
1.84
1.3
1.4
—
—
—
0
0
57
403
1.44
1.83
3.6
3.7
1.3
1.7
mmol/l
0.22
44
296
186
1566
1.24
1.80
4.5
3.5
21.4
23.9
%
1.48
83
699
11
47
2.36
1.78
2.3
2.2
25.0
20.9
nmol/l
0.29
11
42
198
1681
1.23
1.77
2.5
2.1
3.2
2.9
mg/l
0.66
162
1420
177
1486
1.24
1.76
2.1
1.6
1.2
1.0
mg/l
0.27
118
1132
34
217
1.59
1.76
1.1
1.1
—
—
—
0
0
727
6978
1.26
1.75
4.7
4.5
6.0
5.9
mmol/l
0.19
647
6343
55
391
1.43
1.73
2.6
2.3
11.8
14.7
nmol/l
1.92
49
348
182
1536
1.23
1.72
1.8
1.7
471.9
39451416.2
pmol/l
1.88
146
1275
231
1998
1.21
1.72
3.5
2.9
1206.0
1308.9
ng/l
0.21
188
1681
0
47
0.00
1.71
0.0
1.5
—
—
—
0
0
0
47
0.00
1.71
0.0
1.2
—
—
—
0
0
7
164
0.42
1.67
1.0
1.5
—
—
—
0
0
53
380
1.42
1.61
2.0
1.6
—
—
—
0
0
33
216
1.55
1.56
1.1
1.1
—
—
—
0
0
131
1082
1.25
1.51
3.0
2.5
0.6
0.7
ug/l
1.35
75
695
7
27
2.61
1.51
1.9
2.1
—
—
—
0
0
748
7235
1.25
1.46
5.1
5.0
2.8
2.8
mmol/l
0.07
671
6671
27
172
1.59
1.44
1.3
1.3
—
—
—
0
0
37
254
1.48
1.43
1.9
1.8
1.4
1.5
g/l
0.49
28
222
17
96
1.79
1.39
1.1
1.3
—
—
—
0
0
14
74
1.91
1.39
1.1
1.3
—
—
—
0
0
7
149
0.47
1.32
1.0
1.4
—
—
—
0
0
7
149
0.47
1.32
1.0
1.4
—
—
—
0
0
7
149
0.47
1.32
1.0
1.4
—
—
—
0
0
7
149
0.47
1.32
1.0
1.4
—
—
—
0
0
181
1568
1.20
1.32
1.2
1.3
2.2
1.7
u/ml
0.17
56
435
86
691
1.27
1.28
7.7
6.6
1.6
1.4
mmol/l
0.16
72
532
30
203
1.50
1.26
1.2
1.2
—
10.0
—
0
36
6
25
2.41
1.24
1.3
1.4
—
—
—
0
0
110
913
1.23
1.24
8.7
6.6
—
—
—
0
0
78
622
1.28
1.23
2.5
2.5
3.4
7.6
ug/l
4.43
59
551
12
63
1.92
1.23
1.2
1.1
—
70.3
—
0
7
5
19
2.64
1.21
3.8
4.4
—
—
—
0
0
8
38
2.12
1.18
1.1
1.6
—
—
—
0
0
727
7051
1.19
1.14
4.6
4.4
1.4
1.5
mmol/l
1.21
656
6495
7
30
2.34
1.12
1.1
1.3
64.4
15.4
ug/l
—
7
30
703
6802
1.18
1.11
4.1
4.0
1.4
1.3
mmol/l
1.80
629
6220
14
82
1.72
1.05
1.3
1.4
—
—
—
0
0
731
7106
1.19
1.04
4.6
4.4
4.7
4.7
mmol/l
0.12
664
6568
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
22
2.28
1.03
1.4
3.0
154.4
125.1
%
—
5
22
5
22
2.28
1.03
1.0
1.5
—
—
—
0
0
5
22
2.28
1.03
1.0
1.5
—
—
—
0
0
9
49
1.85
0.98
1.1
1.6
—
—
—
0
0
52
407
1.30
0.98
4.3
3.2
4.3
4.6
pmol/l
0.95
46
350
18
116
1.56
0.97
1.4
1.5
—
—
—
0
0
140
1223
1.17
0.95
1.3
1.5
—
—
—
0
0
8
145
0.55
0.93
1.5
1.7
—
—
—
0
0
23
159
1.46
0.92
1.0
1.2
—
43.4
—
0
14
186
1667
1.15
0.90
1.7
1.5
20.6
21.1
nmol/l
0.17
154
1425
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
160
1.45
0.89
2.0
2.7
0.4
0.3
u/ml
0.17
16
91
6
29
2.08
0.89
5.5
1.5
—
—
—
0
0
6
29
2.08
0.89
5.5
1.5
—
—
—
0
0
83
696
1.21
0.89
2.0
1.8
—
—
—
0
0
63
514
1.24
0.87
10.8
6.3
9.7
9.8
mmol/l
0.05
55
487
8
45
1.78
0.84
1.4
1.3
—
—
—
0
0
18
121
1.50
0.83
1.2
1.5
—
—
—
0
0
27
197
1.38
0.83
1.2
1.2
—
2.5
—
0
22
69
573
1.22
0.83
2.7
3.0
135.2
193.0
ng/l
0.92
60
532
23
163
1.42
0.82
1.9
2.5
3.7
3.6
g/l
0.08
23
157
11
65
1.70
0.82
1.2
1.5
—
—
—
0
0
12
73
1.65
0.82
1.2
1.1
—
—
—
0
0
33
250
1.33
0.81
1.4
2.1
—
—
—
0
0
10
58
1.73
0.80
2.5
3.4
—
—
—
0
0
82
696
1.20
0.79
2.0
1.7
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
16
106
1.52
0.79
1.1
1.1
—
—
—
0
0
6
33
1.82
0.79
1.2
1.0
—
—
—
0
0
12
74
1.63
0.78
1.2
1.1
—
—
—
0
0
12
74
1.63
0.78
1.2
1.1
—
—
—
0
0
9
54
1.67
0.74
1.3
1.5
0.8
1.0
g/l
—
9
54
16
108
1.49
0.74
1.3
1.1
53.9
77.4
iu/ml
—
7
23
7
39
1.80
0.72
1.1
2.4
705.7
1094.9
u/ml
—
7
39
9
57
1.58
0.71
1.6
1.5
—
—
—
0
0
29
221
1.32
0.70
4.1
1.3
9.0
10.5
g/l
0.85
20
185
26
195
1.34
0.70
2.9
2.2
11312.6
2478.6
u/l
—
10
87
26
195
1.34
0.70
4.2
1.3
0.9
0.4
g/l
0.25
15
169
13
85
1.54
0.69
1.4
1.3
—
—
—
0
0
12
77
1.57
0.68
1.2
1.1
—
—
—
0
0
12
77
1.57
0.68
1.2
1.1
—
—
—
0
0
19
136
1.41
0.67
2.4
1.9
192.8
228.2
pmol/l
0.72
19
128
90
784
1.17
0.67
1.4
1.8
1.6
1.5
%
0.55
80
684
25
188
1.34
0.67
1.8
2.1
88.2
93.1
%
0.51
20
178
43
349
1.24
0.66
1.0
1.0
—
—
—
0
0
16
112
1.44
0.64
1.4
1.6
—
—
—
0
0
5
30
1.67
0.61
1.2
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
278.5
—
0
13
8
52
1.54
0.59
1.1
1.2
—
—
—
0
0
8
52
1.54
0.59
1.1
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
11
72
1.53
0.59
14.1
7.1
8.3
7.5
mmol/l
0.27
11
56
14
97
1.45
0.59
1.1
1.4
—
—
—
0
0
8
53
1.51
0.58
1.1
1.2
—
—
—
0
0
8
53
1.51
0.58
1.1
1.2
—
—
—
0
0
8
53
1.51
0.58
1.1
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
12
82
1.47
0.54
1.6
1.5
—
—
—
0
0
30
240
1.26
0.54
4.0
1.3
6.9
7.4
g/l
1.08
18
174
30
240
1.26
0.54
4.0
1.3
3.0
3.8
g/l
2.52
17
167
30
240
1.26
0.54
4.0
1.3
—
—
—
0
0
22
283
0.77
0.54
1.3
1.5
—
—
—
0
0
24
187
1.29
0.53
3.9
1.3
38.8
38.2
g/l
0.25
15
156
26
205
1.28
0.53
1.2
1.3
118.4
264.6
miu/ml
—
10
101
6
40
1.50
0.51
2.0
1.6
—
—
—
0
0
67
585
1.16
0.51
4.0
3.2
2.3
2.1
mmol/l
0.18
56
468
33
401
0.82
0.51
2.2
1.9
—
—
—
0
0
13
92
1.42
0.50
1.3
1.1
—
—
—
0
0
16
118
1.36
0.50
1.3
1.2
—
—
—
0
0
12
85
1.42
0.47
1.2
1.3
—
—
—
0
0
31
255
1.22
0.46
1.5
1.8
—
—
—
0
0
11
77
1.43
0.45
1.2
1.1
—
—
—
0
0
14
103
1.37
0.45
1.0
1.1
—
—
—
0
0
44
377
1.18
0.44
1.1
1.3
—
—
—
0
0
23
184
1.26
0.43
2.0
1.9
36.3
39.6
nmol/l
0.43
23
176
5
31
1.62
0.43
1.0
1.4
—
—
—
0
0
98
891
1.11
0.43
20.2
26.2
1.4
1.3
inr
0.32
16
120
8
56
1.43
0.42
1.0
1.0
—
—
—
0
0
16
122
1.32
0.42
1.6
1.7
—
—
—
0
0
22
176
1.26
0.42
1.1
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
1919.0
1847.6
miu/ml
—
5
33
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
27
223
1.22
0.40
4.3
1.3
2.8
3.1
g/l
0.93
17
169
141
1312
1.09
0.39
3.7
3.8
257.1
468.0
ng/l
0.75
103
1012
5
35
1.43
0.39
1.2
6.5
—
36.6
—
0
9
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
97
887
1.11
0.39
5.5
4.7
31.1
32.2
%
0.45
61
590
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
18
142
1.27
0.38
3.4
3.6
0.8
0.8
nmol/l
0.26
12
111
20
162
1.24
0.35
4.4
1.3
0.0
0.0
g/l
0.00
15
146
15
189
0.79
0.34
1.3
1.5
—
—
—
0
0
10
73
1.37
0.34
1.1
1.4
—
—
—
0
0
17
137
1.25
0.32
1.3
1.2
—
—
—
0
0
13
163
0.79
0.29
1.1
1.2
5.3
3.9
mmol/l
0.73
13
154
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
13
104
1.25
0.26
1.2
1.2
338.4
234.4
u/ml
—
7
64
29
329
0.88
0.25
2.2
1.8
—
—
—
0
0
27
236
1.15
0.24
1.6
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
20
173
1.16
0.21
1.2
1.4
316.8
317.4
ug/g
0.00
11
102
11
89
1.24
0.21
1.1
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
25
282
0.88
0.20
1.1
1.7
2.4
3.3
mg/l
0.53
14
203
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
6
53
1.13
0.18
1.7
1.3
5.7
7.4
u/l
—
6
45
20
175
1.15
0.18
4.4
1.3
0.0
0.0
g/l
0.50
15
158
196
1898
1.04
0.18
1.7
1.6
1.5
1.4
mmol/l
1.01
154
1595
54
505
1.07
0.16
1.4
1.2
71.9
132.9
iu/ml
1.70
20
209
14
123
1.14
0.12
1.2
1.4
—
—
—
0
0
14
123
1.14
0.12
1.2
1.4
—
—
—
0
0
12
104
1.16
0.12
1.2
1.5
—
—
—
0
0
20
182
1.10
0.11
2.4
3.3
—
—
—
0
0
22
239
0.92
0.10
1.4
1.4
—
—
—
0
0
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
78
755
1.04
0.08
1.6
2.0
—
—
—
0
0
6
56
1.07
0.08
2.2
2.0
—
—
—
0
0
5
61
0.82
0.08
2.2
1.3
—
—
—
0
0
18
195
0.92
0.08
2.9
2.3
157.4
73.7
ug/min
—
8
124
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
37
386
0.96
0.06
2.0
1.5
—
—
—
0
0
20
188
1.07
0.05
1.3
1.3
—
—
—
0
0
17
181
0.94
0.05
1.2
1.2
452.4
467.9
mg/l
0.12
17
170
11
119
0.92
0.04
1.1
1.2
22.1
15.8
u/l
0.26
11
105
61
623
0.98
0.03
1.7
1.7
—
—
—
0
0
69
677
1.02
0.03
1.5
1.9
—
—
—
0
0
10
93
1.08
0.02
1.1
1.0
—
—
—
0
0
19
197
0.96
0.01
1.1
1.1
0.6
6.9
u/ml
—
6
24
13
132
0.98
0.00
1.2
1.5
—
—
—
0
0
56
558
1.00
0.00
3.7
2.0
27.3
36.8
u/l
1.60
47
461
160
1597
1.00
0.00
5.1
3.8
1.0
1.0
kg/l
0.02
21
221
40
399
1.00
0.00
4.8
2.7
123.4
129.9
g/l
1.10
40
390
10
99
1.01
0.00
1.2
1.3
0.6
0.6
nmol/l
—
10
92
5
57
0.88
0.00
1.2
1.2
—
—
—
0
0
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
7
79
0.89
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
5
52
0.96
0.00
2.2
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_LOWERLIMB_EXALLC – Benign neoplasm: Connective and other soft tissue of lower limb, including hip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).